Click here to unsubscribe from our email list or mark as SPAM .
Please add us to your address book or whitelist us. Directions for whitelisting are here.

The Game-Changing Pill That May Save Millions of Hearts

Still battling stubborn cholesterol even with statins? You’re not alone—and now, there’s something new that could tip the scales in your favor.

In a major global study led by Monash University, researchers unveiled Obicetrapib, a next-gen cholesterol-lowering pill that does what many treatments can’t. Not only does it cut LDL by 32.6%, it also slashes levels of Lipoprotein(a)—a sneaky genetic factor tied to heart attacks and strokes that’s been nearly untouchable until now.

Backed by results from the prestigious BROADWAY trial and published in the New England Journal of Medicine, this once-daily capsule could soon become a lifeline for millions who’ve hit a wall with standard care.

👉 Learn how Obicetrapib could redefine heart health — and if you might benefit.

You opted in to receive these emails when you requested information or entered one of our contests. You can Manage Subscription here if you do not want to receive these emails any longer. To help make sure we make it into your inbox, add [email protected] to your address book.